🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great pic Assaf, congratulations!!

Dr. Ana Kiess Johns Hopkins Medicine and I wrote an ASTRO blog post for #radonc docs on radiopharmaceutical therapies in #oncology. Don't forget to register for the #Theranostics Training Course at #ASTRO19 on Sept 14 2019! astro.org/Blog/July-2019…

Best in the business... For each eligible employee, Johns Hopkins University pays for 50% of each dependent child's undergraduate tuition+fees. This is a $53,740 per child, per year. If both partners/spouses are FTEs, then the benefit is $107,480. Your kid(s) can enroll in any university

This is quite the slide $MRK

Our lab’s inaugural manuscript is out (PMID: 31424293)!!! First #tweetorial (1/n) #chemtwitter #radonc #academicchatter #newPI #sciencetwitter #livercancer tinyurl.com/y3rh7hq4

We are thrilled to have Simon Cherry at Johns Hopkins Radiology and exited to learn more about UC Davis EXPLORER project!

With a 5-year min follow-up, the combination of nivolumab plus ipilimumab associated with 5-year survival of 52% in patients with metastatic #melanoma, compared with 44% for nivolumab alone and 26% for ipilimumab alone. See the CheckMate 067 trial. #ESMO19 nej.md/2mKBiso

Transformative work Mikhail and team. Congratulations!!!

Come and join our team! #PhD opportunity on FindAPhD: We are looking for a talented student interested in understanding how #cancer cells respond to #DNAdamage. We can even visualise this process in vivo! Details here: findaphd.com/search/Project…. Pls get in touch. RTs appreciated

2019 Medicine Laureates William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza have identified molecular machinery that regulates the activity of genes in response to varying levels of oxygen. #NobelPrize

Congratulations to Dr Gregg Semenza from Johns Hopkins Medicine on being awarded the 2019 The Nobel Prize in Physiology or Medicine for work focused on how cells detect and respond to oxygen. He shares the honor with Dr William Kaelin and Sir Peter Ratcliffe. hub.jhu.edu/2019/10/07/gre…

Registration for our workshop Johns Hopkins Radiology Johns Hopkins Medicine "Precision Imaging Agents and Theranostics: Concept to Clinic” is now open! Emphasis on clinical translation of #PET and #MR imaging agents. Approved for #CME credits. hopkinscme.cloud-cme.com/default.aspx?P… RTs are appreciated.

The first woman to be awarded a #NobelPrize, the first individual to be awarded two Nobel Prizes and still today the only individual with two Nobel Prizes in two different scientific categories - Marie Skłodowska Curie.

Dr. Martin Pomper Past-President of WMIS delivered a compelling Plenary at ESNM today where he showed his Journey imaging PSMA starting in 1997. He stated PSMA imaging is leading us in the direction of a paradigm shift and a path to cure with imaging.

Congratulations Jason! A fantastic recognition to everything that you do.

Nice work by Dr. Sridhar Nimmagadda & colleagues Sridhar Nimmagadda We now have an exciting study of a novel PD-L1 PET tracer (developed by Dr. Nimmagadda in his lab at Johns Hopkins) open for pts starting pembrolizumab for lung cancer Johns Hopkins Thoracic Oncology Johns Hopkins Kimmel Cancer Center #LCSM

Congratulations to Jason Lewis, Ph.D. and Martin Pomper, Ph.D.! Dr. Lewis and Dr. Pomper will receive our highest honor, the Gold Medal Award for Outstanding Contributions to Molecular Imaging at #WMIC2021. We hope to see you there! Register here: ow.ly/hBGq50GhrpR

Collecting biopsies isn't easy for patients who have multiple #Cancers. So, Johns Hopkins Medicine researchers developed an agent that marks so-called immune checkpoints in the whole body non-invasively for imaging. 1/3 bit.ly/3kNTqND

The new labeling agent could help us monitor differences in checkpoint expression across the body and allow oncologists to compare the performance of different antibody therapies. bit.ly/3kNTqND 2/3

We show that PD-L1 imaging agents can be used as a common denominator to compare the activity of different antibodies. This will allow us to compare the efficacy of different antibodies early in therapy, identify better drugs and optimize the doses. bit.ly/3kNTqND 3/3